# Dexamedtomidine in Control of Intracranial Pressure in Preeclampsia

> **NCT05119101** · PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Intracranial Pressure Control in Pre-eclampsia

## Interventions

- **DRUG:** Dexamedotomidine added to Magnesium sulfate
- **DRUG:** Magnesium sulfate

## Key facts

- **NCT ID:** NCT05119101
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-10
- **Final completion:** 2023-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05119101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05119101, "Dexamedtomidine in Control of Intracranial Pressure in Preeclampsia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05119101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
